Matches in Wikidata for { <http://www.wikidata.org/entity/Q91034014> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q91034014 description "article scientifique publié en 2018" @default.
- Q91034014 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91034014 description "scientific article published on 19 August 2018" @default.
- Q91034014 description "wetenschappelijk artikel" @default.
- Q91034014 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91034014 name "Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy" @default.
- Q91034014 name "Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy" @default.
- Q91034014 type Item @default.
- Q91034014 label "Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy" @default.
- Q91034014 label "Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy" @default.
- Q91034014 prefLabel "Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy" @default.
- Q91034014 prefLabel "Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy" @default.
- Q91034014 P1433 Q91034014-5D22A4C5-47D7-486A-B900-5F696CCE40C6 @default.
- Q91034014 P1476 Q91034014-90A45DF0-7D9E-4F4F-AC55-223CD6E2CA76 @default.
- Q91034014 P2093 Q91034014-41284AF9-92FF-427C-96FA-0C2CBE83E7D7 @default.
- Q91034014 P2093 Q91034014-64218EB7-DFC9-4272-B352-955F9C6791E6 @default.
- Q91034014 P2093 Q91034014-99E86EB3-D825-4630-B84D-8C5E0536255F @default.
- Q91034014 P304 Q91034014-4ACE9600-3639-4B33-A001-9FCF7FB21FF8 @default.
- Q91034014 P31 Q91034014-849938A0-953E-4CC9-9567-ACDDF3F1F95A @default.
- Q91034014 P356 Q91034014-E1003CE7-FE88-4CE7-B7EC-60803D5DDC2D @default.
- Q91034014 P433 Q91034014-869F557E-D03B-4667-ACFA-08178AECC24F @default.
- Q91034014 P478 Q91034014-B02E6D95-5356-479B-A7C1-64D521C12D4D @default.
- Q91034014 P577 Q91034014-8D6B5CF3-BA11-4B95-B7B5-D1745D0EB1F7 @default.
- Q91034014 P698 Q91034014-8895C93E-CA71-4C75-92B1-D98C35C6EC86 @default.
- Q91034014 P356 1078155218793709 @default.
- Q91034014 P698 30124124 @default.
- Q91034014 P1433 Q6295681 @default.
- Q91034014 P1476 "Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy" @default.
- Q91034014 P2093 "Amber Draper" @default.
- Q91034014 P2093 "Ragini Kudchadkar" @default.
- Q91034014 P2093 "Tyler Beardslee" @default.
- Q91034014 P304 "1275-1281" @default.
- Q91034014 P31 Q13442814 @default.
- Q91034014 P356 "10.1177/1078155218793709" @default.
- Q91034014 P433 "5" @default.
- Q91034014 P478 "25" @default.
- Q91034014 P577 "2018-08-19T00:00:00Z" @default.
- Q91034014 P698 "30124124" @default.